We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NRC market cap is 831.8M. The company's latest EPS is USD 1.2983 and P/E is 26.90.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 37.69M | 38.14M | 36.47M | 36.16M | 37.95M |
| Operating Income | 11.11M | 12.24M | 9.02M | 9.36M | 9.96M |
| Net Income | 8.3M | 6.64M | 6.96M | 7.27M | 7.88M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 127.98M | 133.28M | 147.95M | 151.57M | 148.58M |
| Operating Income | 43.04M | 42.14M | 50.59M | 46.54M | 40.05M |
| Net Income | 32.41M | 37.26M | 37.47M | 31.8M | 30.97M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 134.98M | 130.46M | 134.31M | 133.63M | 120.14M |
| Total Liabilities | 67.22M | 58.43M | 59.64M | 55.88M | 62.26M |
| Total Equity | 67.77M | 72.03M | 74.67M | 77.75M | 57.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 110.69M | 133.42M | 157.54M | 130.46M | 122.44M |
| Total Liabilities | 77.79M | 69.11M | 72.2M | 58.43M | 73.48M |
| Total Equity | 32.89M | 64.32M | 85.34M | 72.03M | 48.96M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 28.16M | 36.27M | 7.75M | 16.59M | 26.41M |
| Investing | -7.87M | -9.84M | -3.2M | -7.54M | -12.01M |
| Financing | -46.04M | -55.58M | -5.86M | -11.58M | -35.6M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 40.92M | 40.64M | 46.34M | 36.27M | 38.11M |
| Investing | -4.66M | -3.72M | -8.51M | -9.84M | -15.78M |
| Financing | -36.35M | -15.5M | -18.16M | -55.58M | -40.71M |
| Market Cap | 831.8M |
| Price to Earnings Ratio | 26.90 |
| Price to Sales Ratio | 5.61 |
| Price to Cash Ratio | 125.21 |
| Price to Book Ratio | 17.02 |
| Dividend Yield | 1.38% |
| Shares Outstanding | 23.85M |
| Average Volume (1 week) | 50.23k |
| Average Volume (1 Month) | 47.43k |
| 52 Week Change | -20.52% |
| 52 Week High | 47.25 |
| 52 Week Low | 32.08 |
| Spread (Intraday) | 9.91 (24.77%) |
| Company Name | National Research Corporation |
| Address |
777 e wisconsin ave milwaukee, wisconsin 53202 5367 |
| Website | https://www.nrchealth.com |
| Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
